Cost-effectiveness analysis of denosumab versus alendronate for improving bone mineral density in renal transplant recipients: a comparative study

• Główni autorzy: Mona Alshahawey (Autor), May A Shawki (Autor), Sherihan Ahmed Sayed (Autor), Ahmad Elseasi (Autor), Lamia ElWakeel (Autor)
• Format: Książka
• Wydane: SpringerOpen, 2024-10-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Abstract Background Denosumab and alendronate had a positive impact on bone mineral density (BMD) preservation after kidney transplantation. However, the cost-effectiveness of these agents in the context of kidney transplantation remains largely unexplored. We have conducted a cost-effectiveness ana...